| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,160,000 | 3,308,000 | 3,276,000 | 3,143,000 | | Cost of Revenue | 65,000 | 214,000 | 320,000 | (731,000) | | | Gross Profit | 2,095,000 | 3,094,000 | 2,956,000 | 3,874,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,253,000 | 1,934,000 | 2,164,000 | 2,996,000 | | Non Recurring | 1,000 | 333,000 | 30,000 | 23,000 | | Others | 118,000 | 95,000 | (266,000) | 336,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 723,000 | 732,000 | 1,028,000 | 519,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 723,000 | 732,000 | 1,028,000 | 519,000 | | Interest Expense | 109,000 | 370,000 | 182,000 | (312,000) | | Income Before Tax | 614,000 | 362,000 | 846,000 | 831,000 | | Income Tax Expense | 138,000 | 106,000 | 369,000 | 283,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 476,000 | 256,000 | 477,000 | 548,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 476,000 | 256,000 | 477,000 | 548,000 | | Preferred Stock And Other Adjustments |
-
| (22,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $476,000 | $234,000 | $477,000 | $548,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
